However, we found that CD48 expression was decreased in Tregs from metastatic tumor tissues, suggesting that although the proportion of Tregs increased, their immunosuppressive capacity may be diminished in the metastatic tumor microenvironment. The gene discussed is CD48; the disease is neoplasm.